Squamous Cell Carcinoma (Skin)
6
2
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (6)
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Skin Cancer and Hyperthermia and Radiotherapy
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions